“We are going to drive for improvement, but right now the focus really is, let's make sure we have the supply ready, we have the market ready to bring this important innovation to the market, and then we'll talk about how do we accelerate,”

Rob Davis · said 2026-10-14 · reported 2026-10-14

Merck CEO Rob Davis told CNBC in an exclusive interview that he expects the company's personalized cancer vaccine with Moderna to get faster to manufacture over time.